We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS

Delisted

DALS was delisted on the 28th of July, 2023.

Back to rankings

45 hedge funds and large institutions have $140M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2% more funds holding

Funds holding: 44 → 45 (+1)

7% less capital invested

Capital invested by funds: $150M → $140M (-$10.8M)

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
+$2.5M
2
CF
Cantor Fitzgerald
New York
+$1.6M
3
CSS
Cubist Systematic Strategies
Connecticut
+$1.37M
4
SCM
Saba Capital Management
New York
+$1.34M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.22M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$4.86M
2
ACA
Arena Capital Advisors
California
-$2.5M
3
PVI
Pura Vida Investments
New York
-$1.6M
4
SCM
Soleus Capital Management
Connecticut
-$486K
5
UFM
Ursa Fund Management
California
-$243K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIMCA
26
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.24M – – –
Toronto Dominion Bank
27
Toronto Dominion Bank
Ontario, Canada
$1.07M – – –
CIM
28
Cowen Investment Management
New York
$969K – – –
EAM
29
Exos Asset Management
New York
$736K -$9.94K -1,022 -1%
FTCM
30
Fir Tree Capital Management
New York
$734K -$19.8K -2,034 -3%
MP
31
Mangrove Partners
Connecticut
$711K +$714K +73,356 New
ACA
32
Arena Capital Advisors
California
$669K -$2.5M -257,328 -79%
SCM
33
Soleus Capital Management
Connecticut
$485K -$486K -50,000 -50%
COPPSERS
34
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$485K – – –
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$446K – – –
PSC
36
Piper Sandler & Co
Minnesota
$242K – – –
HF
37
HRT Financial
New York
$164K +$1.88K +193 +1%
SFM
38
Spartan Fund Management
Canada
$144K – – –
SSA
39
Schonfeld Strategic Advisors
New York
$130K +$130K +13,389 New
PHK
40
Point72 Hong Kong
Hong Kong
$122K – – –
CCMU
41
Cheyne Capital Management (UK)
United Kingdom
$97K – – –
MF
42
Magnetar Financial
Illinois
$9.62K +$15.4K +1,584 +0.2%
WAM
43
Wolverine Asset Management
Illinois
$9K +$9.73K +1,000 New
UBS Group
44
UBS Group
Switzerland
$2K – – –
SCM
45
Segantii Capital Management
Hong Kong
$969 – – –
PA
46
Perceptive Advisors
New York
– -$4.86M -500,000 Closed
PVI
47
Pura Vida Investments
New York
– -$1.6M -164,834 Closed
UFM
48
Ursa Fund Management
California
– -$243K -25,000 Closed
Bank of America
49
Bank of America
North Carolina
– -$242K -24,941 Closed
AA
50
Ancora Advisors
Ohio
– -$6K -600 Closed
1
2

DALS Hedge Fund Activity: Q2 2022 in Review

45 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q2 2022, worth a combined $140M — down 7.2% from $150M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new DALS positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 4 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $2.5M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $4.86M sold.

  • 45 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q2 2022, up from 44 in Q1 2022.
  • Funds reported $140M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q2 2022, down 7.2% quarter-over-quarter.
  • 6 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q2 2022 and 5 closed out, a net change of +1 holder.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q2 2022 was AQR Arbitrage, an estimated $2.5M added.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q2 2022 was Perceptive Advisors, an estimated $4.86M sold.

Based on aggregated 13F filings for Q2 2022.